MSH Advanced CV Imaging Fellowship

Check out our brand new Advanced CV Imaging Fellowship Website! icahn.mssm.edu/education/resi… @doctorginaL @SWBienMD @DLBHATTMD @lesleejshaw @MountSinaiHeart @SinaiCards @MSHCardsCT @MSH_MedChiefs

⚠️Women may not need as much coronary plaque as men to get into trouble. 🫀New @CircAHA analysis quantified total plaque burden (plaque volume/vessel volume) in 4267 patients with CP undergoing #CCTA. Women had less plaque and lower plaque volumes, but risk “turned on” earlier:

Adam Jacobi, head of cardiothoracic radiology, giving a wonderful talk on imaging endocarditis during our biweekly conference @MSHCVImaging @SWBienMD @SinaiCards @MountSinaiHeart

🚨 New study in #EJPC: ✅Life’s Essential 8 is inversely associated with HF risk ✅Individuals with initially low LE8 levels experience a reversal in HF risk upon improvement 💻 ow.ly/EoEF50X01cN @EJPCEiC @AboyansV @EAPCPresident @SilCastelletti @PeroneFrancesco @PTBuketAkinci @justvick

🌟🌟Coronary artery disease: a BIG movement to change from reactive end-stage treatment to early detection and treatment: thelancet.com/action/showPdf… Kudos to the The Lancet Commission for actively studying the global health benefits of this paradigm shift from "ischemic" heart disease to atherosclerosis!🌟🌟

A major advancement in cardiovascular care: A new international study led by Deepak L. Bhatt, MD, MPH, MBA, Director of Mount Sinai Fuster Heart Hospital, has found that sotagliflozin, an FDA-approved SGLT inhibitor for type 2 diabetes and kidney disease, significantly reduces heart attacks and strokes. Published in The Lancet Diabetes & Endocrinology, the trial is the first to demonstrate these unique benefits from dual SGLT1 and SGLT2 inhibition. The findings could shift how we treat cardiovascular risk in patients with diabetes and chronic kidney disease. Read the Specialty Report here: mshs.co/4muq1oZ

#cardiology #cardiovascular #cardiotwitter #cardioX

Welcome to our new imaging fellows! Grateful for our brand new imaging fellow room. A lot of education, academic collaboration, and teamwork happening here! @DLBHATTMD @lesleejshaw @SWBienMD @SinaiCards @MSHCardsCT

Welcome to all the new #cardiology general and subspecialty fellows at @MountSinaiHeart! #cardiovascular #cardiotwitter #cardioX @DoctorKini @DrDavidReich @IcahnMountSinai @MountSinaiNYC

Welcome to our new advanced CV imaging fellow, Dr. Shreyans Patel! We are lucky to have him and cannot wait for a fun, educational, and enriching year ahead. @MountSinaiHeart @SinaiCards @MSHCardsCT @DLBHATTMD @lesleejshaw

@MichaelHadleyMD @Jcontreras75

Wonderful system-wide multimodality imaging conference this morning! An absolute wonderful discussion regarding advanced CV imaging and heart transplant rejection!

Introducing our new CV Imaging Fellow for 2024-2025! Welcome! Stephanie Jou, MD Fellowship: The Mount Sinai Hospital Residency: Columbia University Medical School: Albany Medical College @SinaiCards @DLBHATTMD @doctorginaL @SWBienMD @lesleejshaw @MichaelHadleyMD

Systemic inflammation & plaque progression by #YesCCT? Study alterations in atherosclerotic plaque progression were correlated w/ Hs-CRP. Total plaque progression was 1.4-fold higher. bit.ly/3OSgGc8 #JACCIMG #PARADIGM @SWBienMD @RonBlankstein @lesleejshaw

❗Just published❗Transcatheter Aortic Valve Replacement in a Patient With Quadricuspid Aortic Valve Stenosis and Regurgitation. Read here: okt.to/R1H5ls @DLBHATTMD @LucySafi #cardioTwitter #cardiology #interventionalcardiology #TAVR #aorticstenosis

Now in @ESC_Journals, our group presents an incredible case of significant plasmacytoma regression by CMR! Check it out ⬇️⬇️⬇️ tinyurl.com/4uybyphe @SWBienMD @doctorginaL @ferresc92 @MichaelHadleyMD @SinaiCards @MountSinaiHeart

Great combo: structural ❤️ bootcamp + social for team building with our @MountSinaiHeart @MountSinaiNYC @IcahnMountSinai A++ structural ❤️interventional & imaging fellows! 🙏🏼@MDT_StructHeart @AbbottCardio for ur partnership! @DoctorKini @KHERA_MD @ParasuramMD @LucySafi

Now in @ESC_Journals, our group presents an incredible case of significant cardiac amyloidosis regression by CMR and Echo Strain. tinyurl.com/4zyvh2k4 @SWBienMD @doctorginaL @ferresc92 @MichaelHadleyMD @SinaiCards @MountSinaiHeart

Our editorial in EHJ commenting on the 12-month TRISCEND results in TR with the Evoque valve wherein we discuss our insights across the major experiences with TriClip and TTVR. academic.oup.com/eurheartj/adva…

Now out in @JACCJournals! From the multinational PARADIGM registry, our results reveal that inflammation (hsCRP) identified patients at high risk for atherosclerosis progression and CAD events. @lesleejshaw @RonBlankstein @LubbDup @JonathonLeipsic tinyurl.com/fe6aa7uf

Check out our multimodality imaging conference from across @MountSinaiNYC @MountSinaiHeart Held every month, it is a wonderful educational experience! See below 👇👇👇 youtube.com/watch?v=5FUHqV…